Home
|Insights
|The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

PDF Link

The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

Publication | 09.18.15

Contacts

Barbara H. Ryland
Senior Counsel
- Washington, D.C.
  - D | +1.202.624.2970
YnJ5bGFuZEBjcm93ZWxsLmNvbQ==
Deborah H. Yellin
Partner
She/Her/Hers
- Washington, D.C.
  - D | +1.202.624.2947
ZHllbGxpbkBjcm93ZWxsLmNvbQ==

Insights

Publication | 06.26.25

A Changed IRS May Finally End Conservation Easement Legal Mess

Publication | 06.26.25
Conducting Investigations And Discovery In China, Part II: Navigating Judicial And Regulator Expectations In Cross-Border Reviews
Publication | 06.26.25
Is Section 230 Going To Change? The FTC, DOJ And FCC Signal Significant Change For Online Businesses
Publication | 06.25.25
4 Precautions For Responsible AI Use In Bid Protests

View All Insights

Subscribe

to the latest insights from our team